Categories: News

Integral Consulting and ScitoVation Announce Strategic Alliance to Advance Innovation in Health Risk Assessment

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

BOULDER, Colo. and DURHAM, N.C., March 12, 2025 /PRNewswire/ — Integral Consulting Inc. and ScitoVation, LLC, are excited to announce a strategic alliance aimed at transforming health risk assessment. By integrating their scientific expertise and leveraging advanced data analysis, the partnership will deliver innovative solutions to complex toxicological and exposure assessment challenges.

Integral Consulting brings extensive experience in exposure science, toxicology and epidemiology, data management, and environmental economics, offering deep insight into regulatory challenges and risk mitigation strategies. ScitoVation, a leader in New Approach Methodologies (NAMs) and computational toxicology, enhances the partnership with cutting-edge AI-driven data analytics, physiologically based pharmacokinetic (PBPK) modeling, and omics-based toxicological assessments.

Together, these industry leaders provide clients one stop for comprehensive scientific approaches to chemical safety assessment. The result is accelerated innovation and increased confidence in outcomes:

  • Using AI-driven tools to address toxicology data gaps and reduce in vivo testing
  • Characterizing exposure from emission source to target cell to population
  • Optimizing risk mitigation strategies through advanced data integration.

“This partnership enhances our ability to hasten the development and adoption of new tools that will enable our clients to determine the safety of compounds faster and more efficiently,” said Jean-Guilmond (Sammy) Orelien, DrPH, MStat, CEO of ScitoVation.

“Confidence in chemical safety assessments is often hindered by data gaps that increase uncertainty. Our integrated tool kits will enable solutions to address these gaps,” noted Andy Maier, Ph.D., CIH, DABT of Integral Consulting.

Judi Durda, Senior Principal and Initiative Leader shared, “This strategic partnership expands options to address complex chemical safety decisions. Our formal partnership’s focus on continuous improvement and technological advancement will promote human health.”

For more information on this strategic partnership or to engage with ScitoVation and Integral Consulting, please contact:

Judi Durda, Integral Consulting, jdurda@integral-corp.com or 667-225-5414.

About ScitoVation

ScitoVation applies New Approach Methodologies (NAMs) to assess compound safety using computational toxicology, next-generation technology, and scientific expertise. As a contract research organization, ScitoVation helps clients navigate regulatory landscapes and accelerate product innovation.

About Integral Consulting

Integral Consulting Inc. is a national science and engineering firm delivering technical solutions to complex environmental, health, economic, and natural resource challenges faced by our clients. We employ an unrelenting commitment to technical excellence, innovation, and collaboration to address yesterday’s environmental impacts, meet today’s demands, and create a more sustainable tomorrow.

View original content to download multimedia:https://www.prnewswire.com/news-releases/integral-consulting-and-scitovation-announce-strategic-alliance-to-advance-innovation-in-health-risk-assessment-302398921.html

SOURCE Integral Consulting Inc.

Staff

Recent Posts

FinThrive Introduces Agentic AI at HFMA 2025 to Help Customers Transform Healthcare Revenue Cycle Management Performance

Company to also highlight advancements in denials and underpayments management and speak to the measurable…

18 hours ago

FinThrive Debuts Denials and Underpayments Analyzer, a Unified Solution for Denials and Underpayments, at HFMA 2025

Next generation analyzer helps hospitals protect revenue before it's lost by delivering timely end-to-end visibility…

18 hours ago

Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine

Data presented simultaneously at the American Diabetes Association’s® 85th Scientific Sessions, showed mean weight reduction…

21 hours ago

Dr. Anosh Ahmed Advances Chicago Crypto Hub Project as Federal Support for Blockchain Grows

Dr. Anosh Ahmed repurposes West Side warehouse into blockchain innovation center, targeting 250+ jobs and…

21 hours ago

Dr. Anosh Ahmed Advances Chicago Crypto Hub Project Amid National Pro-Crypto Policy Shift

Dr. Anosh Ahmed converts vacant West Side warehouse into blockchain innovation hub, creating 250+ jobs…

21 hours ago

BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions

Treatment with apelin receptor agonist enhanced glycemic control and demonstrated cardioprotective effects, with additive benefits…

21 hours ago